Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Feces metagenome

ABSTRACT: Mouse intestinal microbiome

PROVIDER: PRJNA352304 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR4845000_1.fastq.gz	Fastqsanger.gz
	SRR4845000_2.fastq.gz	Fastqsanger.gz
	SRR4845001_1.fastq.gz	Fastqsanger.gz
	SRR4845001_2.fastq.gz	Fastqsanger.gz
	SRR4845002_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Metagenome sequencing of feces of mouse treated D-galactose or not

Project description:D-galactose orally intake ameliorate DNCB-induced atopic dermatitis by modulating microbiota composition and quorum sensing. The increased abundance of bacteroidetes and decreased abundance of firmicutes was confirmed. By D-galactose treatment, Bacteroides population was increased and prevotella, ruminococcus was decreased which is related to atopic dermatitis.

2022-04-29 | E-MTAB-11632 | biostudies-arrayexpress

Metagenomic sequencing of adult zebrafish feces after SMZ exposure (Exposure of Danio rerio to environmental sulfamethoxazole may contribute to neurobehavioral abnormalities via gut microbiome disturbance)

Project description:The neurotoxic effects and mechanisms of low-dose and long-term sulfamethoxazole (SMZ) exposure remain unknown. This study exposed zebrafish to environmental SMZ concentrations and observed behavioral outcomes. SMZ exposure increased hyperactivity and altered the transcript levels of 17 genes associated with neurological function. It impaired intestinal function by reducing the number of intestinal goblet cells and lipid content. Metabolomic results indicated that the contents of several lipids and amino acids in the gut were altered, which might affect the expression levels of neurological function-related genes. Metagenomic results demonstrated that SMZ exposure substantially altered the composition of the gut microbiome. Zebrafish receiving a transplanted fecal microbiome from the SMZ group were also found to exhibit abnormal behavior, suggesting that the gut microbiome is an important target for SMZ exposure-induced neurobehavioral abnormalities. Multi-omics correlation analysis revealed that gut micrometabolic function was related to differential gut metabolite levels, which may affect neurological function through the gut-brain-axis. Reduced abundance of Lefsonia and Microbacterium was strongly correlated with intestinal metabolic function and may be the key bacterial genera in neurobehavioral changes. This study confirms for the first time that SMZ-induced neurotoxicity in zebrafish is closely mediated by alterations in the gut microbiome.

2024-02-22 | GSE255986 | GEO

Extracellular miRNAs in serum and feces of mice exposed to high-dose radiation

Project description:Exposure to high-dose radiation causes life-threatening serious intestinal damage. Histological analysis is the most accurate method for judging the extent of intestinal damage after death. However, it is difficult to predict the extent of intestinal damage to body samples. Here we focused on extracellular microRNAs (miRNAs) released from cells and investigated miRNA species that increased or decreased in serum and feces using a radiation-induced intestinal injury mouse model. A peak of small RNA of 25–200 nucleotides was detected in mouse serum and feces 72 h after radiation exposure, and miRNA presence in serum and feces was inferred. MiRNAs expressed in the small intestine and were increased by more than 2.0-fold in serum or feces following a 10 Gy radiation exposure were detected by microarray analysis and were 4 in serum and 19 in feces. In this study, miR-375-3p, detected in serum and feces, was identified as the strongest candidate for a high-dose radiation biomarker in serum and/or feces using a radiation-induced intestinal injury model.

2023-12-15 | GSE247876 | GEO

Feces metagenome

Project description:Ecological and evolutionary alteration in the GD intestinal microbiome part01

| PRJNA602729 | ENA

Feces metagenome

Project description:Ecological and evolutionary alteration in the GD intestinal microbiome part02

| PRJNA602731 | ENA

Feces metagenome

Project description:Ecological and evolutionary alteration in the GD intestinal microbiome part04

| PRJNA602733 | ENA

Feces metagenome

Project description:Ecological and evolutionary alteration in the GD intestinal microbiome part03

| PRJNA602732 | ENA

hsa-miR-7704 enriched in feces from patients with hepatic encephalopathy aggravates disease by inhibiting the growth and adhesion of Bifidobacterium longum

Project description:We established an experimental mouse model of HE using thioacetamide (TAA) and examined the alterations in the gut microbiome.

2023-04-19 | GSE228827 | GEO

feces metagenome

Project description:Alterations of gut microbiota in a mouse model with partial small intestinal obstruction

| PRJNA1056815 | ENA

feces metagenome

Project description:Microbiome from diverse natural environments colonize and compete in the mouse gut

| PRJNA542998 | ENA